Why it was recalled
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Product description
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Lot numbers, UPCs & expiration codes
Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0921-2017
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jun 1, 2017
- FDA report date
- Jun 28, 2017
- Quantity
- a) 44168 bottles; b) 24960 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Lucid Pharma LLC
Original FDA data
Every field from FDA enforcement report D-0921-2017, exactly as published.
Show all FDA fields
- City
- East Brunswick
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 77427
- Address
- 2 Tower Center Blvd
- Address (line 2)
- Suite 1101B
- Code information
- Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18
- Postal code
- 08816-1100
- Report date
- Jun 28, 2017
- Product type
- Drugs
- Recall number
- D-0921-2017
- Classification
- Class II
- Recalling firm
- Lucid Pharma LLC
- Product quantity
- a) 44168 bottles; b) 24960 bottles
- Termination date
- Sep 25, 2019
- Reason for recall
- Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Jun 1, 2017
- Initial firm notification
- Letter
- Center classification date
- Jun 16, 2017